Wednesday, April 15, 2009

AstraZeneca to market Crestor in India

AstraZeneca India has introduced Crestor (rosuvastatin) as 5, 10, 20 and 40 mg tablets. The drug is indicated for use in the treatment of dyslipidemia, atherosclerosis and primary hypercholesterolaemia.

The details can be read here.

No comments: